Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Clinical Pharmacology : Advances and Applications
|
August 14, 2012
Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
Mahesh N Samtani, John J Sheehan, Dong-Jing Fu, et al.
Neuropsychiatric Disease and Treatment
|
March 16, 2013
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
Larry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Neuropsychiatric Disease and Treatment
|
April 7, 2023
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
Xu Chen, Xuan Hou, Daisy Bai, et al.
International Clinical Psychopharmacology
|
March 15, 2016
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
Larry Alphs, Henry A Nasrallah, Cynthia A Bossie, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 11, 2022
Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder"
Stephane Borentain, Pooja Desai, Dong-Jing Fu, et al.
Neuropsychiatric Disease and Treatment
|
July 22, 2021
Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials
Bettina Diekamp, Stephane Borentain, Dong-Jing Fu, et al.
Applied Health Economics and Health Policy
|
April 24, 2014
Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder
Sudeep Karve, Michael Markowitz, Dong-Jing Fu, et al.
Journal of Clinical Psychopharmacology
|
June 21, 2016
Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
Dong-Jing Fu, Ibrahim Turkoz, R Bruce Simonson, et al.
Pharmacogenomics
|
October 24, 2014
SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response
Dai Wang, Qingqin Li, Reyna Favis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 13, 2004
Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586
Eric Y Zhang, Dong-Jing Fu, Youngeen A Pak, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Clinical Pharmacology : Advances and Applications
|
August 14, 2012
Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
Mahesh N Samtani, John J Sheehan, Dong-Jing Fu, et al.
Neuropsychiatric Disease and Treatment
|
March 16, 2013
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
Larry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Neuropsychiatric Disease and Treatment
|
April 7, 2023
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
Xu Chen, Xuan Hou, Daisy Bai, et al.
International Clinical Psychopharmacology
|
March 15, 2016
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
Larry Alphs, Henry A Nasrallah, Cynthia A Bossie, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 11, 2022
Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder"
Stephane Borentain, Pooja Desai, Dong-Jing Fu, et al.
Neuropsychiatric Disease and Treatment
|
July 22, 2021
Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials
Bettina Diekamp, Stephane Borentain, Dong-Jing Fu, et al.
Applied Health Economics and Health Policy
|
April 24, 2014
Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder
Sudeep Karve, Michael Markowitz, Dong-Jing Fu, et al.
Journal of Clinical Psychopharmacology
|
June 21, 2016
Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
Dong-Jing Fu, Ibrahim Turkoz, R Bruce Simonson, et al.
Pharmacogenomics
|
October 24, 2014
SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response
Dai Wang, Qingqin Li, Reyna Favis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 13, 2004
Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586
Eric Y Zhang, Dong-Jing Fu, Youngeen A Pak, et al.
Page
of 8